A股核心资产

Search documents
中信证券:关注年内两个关键时点 继续聚焦A股和港股核心资产
Zhi Tong Cai Jing· 2025-03-24 06:59
Key Points - The report from CITIC Securities highlights two critical time points in the year: the first is the external risk landing in early April, which is expected to create trading opportunities, and the second is the synchronization of the economic and policy cycles between China and the U.S. around mid-year, which will provide allocation opportunities for core assets [1][2][3] Group 1: Key Time Points - The first key time point is the external risk landing in early April, including the results of the U.S. trade policy memo and the clarity on "reciprocal tariffs." This is expected to lead to trading opportunities in the technology sector due to its weak macroeconomic correlation and strong industrial catalysts [2][3] - The second key time point is the synchronization of the economic and policy cycles between China and the U.S. in mid-year, which may lead to the fourth round of economic stimulus in China since 2013, as the U.S. faces economic weakening and increased tariff pressures [2][8] Group 2: Trading Opportunities - Following the external risk landing in early April, the technology sector is anticipated to experience new trading opportunities, particularly in the context of the U.S. trade policy developments and the expected adjustments in the macroeconomic environment [3][4] - The report emphasizes that edge AI is likely to be a significant catalyst for market movements, with upcoming product launches, particularly from companies like Xiaomi, expected to boost market sentiment [4][10] Group 3: Investment Focus - The report suggests focusing on core assets in both A-shares and Hong Kong stocks, particularly in sectors such as domestic computing power, edge AI, lithium batteries, military industry, and innovative pharmaceuticals in Hong Kong [10] - Additionally, it recommends paying attention to sectors that may experience potential earnings surprises in Q1, including wind power components, engineering machinery, automotive electronics, and service consumption [10]
一周研读|A股核心资产蓄力上涨
中信证券研究· 2025-03-22 01:01
Core Viewpoint - The article emphasizes the potential for A-share core assets to rise, driven by internal demand policies and a shift towards performance-driven market dynamics as external capital inflow slows down [2][3]. Group 1: Market Strategy - The strategy suggests focusing on A-share and Hong Kong core assets, particularly in high-end manufacturing, AI, innovative pharmaceuticals, and smart vehicles, which are seen as "new core assets" with strategic allocation value [3]. - It highlights the importance of sectors such as domestic computing power, edge AI, lithium batteries, military industry, Hong Kong internet, and innovative pharmaceuticals, while also suggesting to monitor supply-side clearing in aluminum, steel, and panels [3]. - The article points out potential overperformance in Q1 reports for segments like wind power components, engineering machinery, automotive electronics, ophthalmic pharmacies, and service consumption [3]. Group 2: Consumption and Policy - The "Consumption Promotion Special Action Plan" has been officially released, indicating a comprehensive upgrade and innovation in consumption policies, with a focus on increasing residents' income and enhancing consumption capacity [12][16]. - The plan aims to stabilize the real estate market, improve service consumption quality, and optimize the environment to unleash consumption potential, with expectations for retail sales growth of around 4.8% by 2025 [12][16]. Group 3: Sector Focus - The article identifies four major themes for investment: new consumption, military industry, quantum computing, and deep-sea technology, suggesting a balanced approach between manufacturing and consumption [4]. - In the deep-sea sector, the government’s focus on deep-sea technology and offshore wind power is expected to drive growth, particularly in companies with advantages in these areas [7]. - The PD-L1 ADC drugs are highlighted for their potential to tap into a global market exceeding $50 billion, with significant clinical developments anticipated in the coming years [8][9].